Millions of Medicare Beneficiaries Use Prescription Drugs That Could Be Subject to Price Negotiation, But Build Back Better Act Provision Exempts Many Drugs With High Federal Spending
(By Juliette Cubanski, Nolan Sroczynski , and Tricia Neuman for Kaiser Family Foundation published January 27, 2022) The Build Back
Read More